Lv64
2880 积分 2021-05-12 加入
Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines
16天前
已完结
Quality Management of Diastereomeric Impurity for Complex Peptide Manufacturing: A Case Study of Corticorelin Ovine
16天前
已完结
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
1个月前
已完结
Considerations for Starting Material Designation for Drug-Linkers in Antibody–Drug Conjugates
1个月前
已完结
Strategies for UF/DF-Based Impurity Removal in the Post-conjugation Purification of Antibody–Drug Conjugates
1个月前
已完结
Cytotoxic Payloads for Antibody – Drug Conjugates
1个月前
已完结
Chemical Linkers in Antibody–Drug Conjugates (ADCs)
1个月前
已完结
practical process research and development
3个月前
已完结
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 1: Synthesis of Two Oligopeptide Fragments
3个月前
已完结
How to Validate a Pharmaceutical Process
4个月前
已完结
皖公网安备34019202002308
